Key result
DHA and neuroprotectin D1 reduce stroke infarct volume up to ~87% in aged rats.
Why the study?
Docosahexaenoic acid improves behavioral deficit and reduces infarct volume and edema after experimental focal cerebral ischemia. The study tested the hypothesis that DHA elicits neuroprotection by inducing AKT/p70S6K phosphorylation to promote cell survival in young and aged rats.
Does intravenous administration of docosahexaenoic acid (DHA) or neuroprotectin D1 (NPD1) 3 hours after stroke onset reduce infarct volume, improve neurobehavioral recovery, and activate AKT survival signaling in young and aged rats after experimental focal cerebral ischemia?
Does intravenous administration of docosahexaenoic acid (DHA) or neuroprotectin D1 (NPD1) 3 hours after stroke onset reduce infarct volume, improve neurobehavioral recovery, and activate AKT survival signaling in young and aged rats after experimental focal cerebral ischemia?
Answers are grounded in this paper and cite their sources.
Systemic administration of DHA or its derivative NPD1 3 hours after experimental ischemic stroke onset confers marked neuroprotection, reduces infarct volume, and activates cell survival signaling in both young and aged rats.
BACKGROUND: Docosahexaenoic acid, a major omega-3 essential fatty acid family member, improves behavioral deficit and reduces infarct volume and edema after experimental focal cerebral ischemia. We hypothesize that DHA elicits neuroprotection by inducing AKT/p70S6K phosphorylation, which in turn leads to cell survival and protects against ischemic stroke in young and aged rats. METHODS AND RESULTS: Rats underwent 2 h of middle cerebral artery occlusion (MCAo). DHA, neuroprotectin D1 (NPD1) or vehicle (saline) was administered 3 h after onset of stroke. Neurological function was evaluated on days 1, 2, 3, and 7. DHA treatment improved functional recovery and reduced cortical, subcortical and total infarct volumes 7 days after stroke. DHA also reduced microglia infiltration and increased the number of astrocytes and neurons when compared to vehicle on days 1 and 7. Increases in p473 AKT and p308 AKT phosphorylation/activation were observed in animals treated with DHA 4 h after MCAo. Activation of other members of the AKT signaling pathway were also observed in DHA treated animals including increases in pS6 at 4 h and pGSK at 24 h. DHA or NPD1 remarkably reduced total and cortical infarct in aged rats. Moreover, we show that in young and aged rats DHA treatment after MCAo potentiates NPD1 biosynthesis. The phosphorylation of p308 AKT or pGSK was not different between groups in aged rats. However, pS6 expression was increased with DHA or NPD1 treatment when compared to vehicle. CONCLUSIONS: We suggest that DHA induces cell survival, modulates the neuroinflammatory response and triggers long term restoration of synaptic circuits. Both DHA and NPD1 elicited remarkable protection in aged animals. Accordingly, activation of DHA signaling might provide benefits in the management of ischemic stroke both acutely as well as long term to limit ensuing disabilities.
No takes yet. Share an insight, caveat, or question.
Eady et al. (2012) studied Experimental ischemic stroke (middle cerebral artery occlusion). Docosahexaenoic acid (DHA) or Neuroprotectin D1 (NPD1) vs. Vehicle (0.9% sodium chloride saline) IV infusion was evaluated on Total infarct volume corrected for brain swelling on day 7 in aged rats (75% reduction with DHA; 87% reduction with NPD1, p=<0.05). Docosahexaenoic acid and neuroprotectin D1 reduced total infarct volume by 75% and 87% respectively and improved neurological recovery at 7 days in aged rats after experimental stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: